ADK:TSV-Diagnos Inc (CAD)

COMMON STOCK | Health Information Services | TSV

Last Closing Price

CAD 0.19

Change

0.00 (0.00)%

Market Cap

CAD 0.01B

Volume

0.01M

Avg Analyst Target

CAD 0.98 (+427.03%)

Avg User Target

CAD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict


ADK Stock Forecast & Price:
Based on the Diagnos Inc stock forecasts from 2 analysts, the average analyst target price for Diagnos Inc is CAD 0.98 over the next 12 months. Diagnos Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Diagnos Inc is Bearish, which is based on 2 positive signals and 5 negative signals. At the last closing, Diagnos Inc’s stock price was CAD 0.19. Diagnos Inc’s stock price has changed by -7.50% over the past week, -7.50% over the past month and -62.63% over the last year.

About Diagnos Inc (ADK:CA:TSV)

DIAGNOS Inc. provides software-based services primarily in Canada, the United States, Colombia, Spain, Mexico, Saudi Arabia, and Costa Rica. The company offers healthcare services through Computer Assisted Retina Analysis, a web-based software tool that assists healthcare profess ...Read More

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2022-09-24 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
RHT:CA Reliq Health Technologies Inc

N/A

CAD0.14B N/A N/A
DOC:CA CloudMD Software & Services In..

N/A

CAD0.08B N/A -1.74
NEWU:CA Newtopia Inc

N/A

CAD0.02B N/A N/A
MNOW:CA Mednow Inc

N/A

CAD0.02B N/A 0.10
VISN:CA Binovi Technologies Corp

N/A

CAD0.01B N/A N/A
CRBK:CA Carebook Technologies Inc

N/A

CAD0.01B N/A -1.25
EYC:CA Binovi Technologies Corp

N/A

CAD0.01B N/A N/A
HMRK:CA Highmark Interactive Inc

N/A

CAD7.81M N/A N/A
KOVO:CA Kovo Healthtech Corp

N/A

CAD7.02M N/A N/A
VGL:CA Vigil Health Solutions Inc

N/A

CAD6.81M 22.06 6.36

ETFs Containing ADK:CA

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Health Information Services)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -45.59% 77% C+ 44% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -45.59% 77% C+ 44% F
Trailing 12 Months  
Capital Gain -62.63% 60% D- 24% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -62.63% 60% D- 24% F
Trailing 5 Years  
Capital Gain -83.18% 33% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -83.18% 33% F 11% F
Average Annual (5 Year Horizon)  
Capital Gain 15.64% 80% B- 59% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 15.64% 80% B- 59% F
Risk Return Profile  
Volatility (Standard Deviation) 119.70% 10% F 27% F
Risk Adjusted Return 13.06% 80% B- 49% F
Market Capitalization 0.01B 54% F 52% F
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Health Information Services)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 54.61 22% F 6% F
Price / Cash Flow Ratio -6.31 77% C+ 38% F
EV/EBITDA -6.16 100% A+ 74% C
Management Effectiveness  
Return on Equity -2,451.57% 11% F 2% F
Return on Invested Capital -248.67% 27% F 7% F
Return on Assets -117.14% 25% F 11% F
Debt to Equity Ratio -732.60% 100% A+ 98% A+
Technical Ratios  
Dividend Yield N/A N/A N/A N/A N/A
Short Ratio N/A N/A N/A N/A N/A
Short Percent 0.19% 67% D+ 17% F
Beta 0.03 100% A+ 88% B+
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector